source
- FDA approves nivolumab plus AVD for untreated advanced-stage Hodgkin lymphomaDr. Alex Herrera, a professor and chief of lymphoma at City of Hope, highlighted the recent FDA clearance of the combination of nivolumab with the chemotherapy regimen AVD for patients with newly d…
- GSK signs $1 billion siRNA partnership with China's SiranBio to target obesityGSK is expanding its cardiometabolic portfolio by entering a new collaboration with Chinese biotech SiranBio. The agreement is valued at $1 billion in biobucks and focuses on developing siRNA ther…